Active Ingredient: DEXLANSOPRAZOLE
Proprietary Name: DEXLANSOPRAZOLE
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A202294
Product Number: 002
Approval Date: Jun 16, 2022
Applicant Holder Full Name: ENDO OPERATIONS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information